Literature DB >> 2996400

Lymphadenopathy-associated virus: from molecular biology to pathogenicity.

L Montagnier.   

Abstract

Recent data indicate that the lymphadenopathy-associated virus (LAV) is morphologically similar to animal lentiviruses, such as equine infectious anemia and visna viruses. This finding, together with the cross-reactivity of the core proteins of LAV with those of the equine infectious anemia virus and a similarity in genome structure and biological properties, allows LAV to be placed in the retroviral subfamily of Lentivirinae. Molecular data indicate a high degree of genetic variation of the virus, especially in the envelope gene, which have important implications for the origin of the virus (the T4 lymphotropism may be a recently acquired property) and for future immunization. Another problem is the role of viral infection in the induction of irreversible immunodeficiency. This syndrome occurs in a minority of infected persons, who generally have in common a past of antigenic stimulation and of immune depression before LAV infection.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Antibodies; Developed Countries; Diseases; Europe; France; Hiv Infections; Immunologic Factors; Immunological Effects; Laboratory Examinations And Diagnoses; Laboratory Procedures; Mediterranean Countries; Proteins; Viral Diseases; Western Europe

Mesh:

Substances:

Year:  1985        PMID: 2996400     DOI: 10.7326/0003-4819-103-5-689

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  14 in total

1.  Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus-related virus protease.

Authors:  Mi Li; Alla Gustchina; Krisztina Matúz; Jozsef Tözsér; Sirilak Namwong; Nathan E Goldfarb; Ben M Dunn; Alexander Wlodawer
Journal:  FEBS J       Date:  2011-10-10       Impact factor: 5.542

2.  Human immunodeficiency virus infection is prevalent in Malawi.

Authors:  J Chiphangwi; G Liomba; H M Ntaba; H Schmidt; F Deinhardt; J Eberle; G Frösner; L Gürtler; G Zoulek
Journal:  Infection       Date:  1987       Impact factor: 3.553

3.  Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome.

Authors:  P N Fultz; H M McClure; R B Swenson; C R McGrath; A Brodie; J P Getchell; F C Jensen; D C Anderson; J R Broderson; D P Francis
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

4.  Motor dysfunction in HIV-infected patients without clinically detectable central-nervous deficit.

Authors:  G Arendt; H Hefter; C Elsing; G Strohmeyer; H J Freund
Journal:  J Neurol       Date:  1990-10       Impact factor: 4.849

5.  Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro.

Authors:  C A Spina; J C Guatelli; D D Richman
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

6.  Transmission of human immunodeficiency virus from parents to only one dizygotic twin.

Authors:  C L Park; H Streicher; R Rothberg
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

7.  Selective alterations in immunoregulatory lymphocyte subsets in early HIV (human T-lymphotropic virus type III/lymphadenopathy-associated virus) infection.

Authors:  J V Giorgi; P G Nishanian; I Schmid; L E Hultin; H L Cheng; R Detels
Journal:  J Clin Immunol       Date:  1987-03       Impact factor: 8.317

Review 8.  Factor VIII, HIV and AIDS in haemophiliacs: an analysis of their relationship.

Authors:  E Papadopulos-Eleopulos; V F Turner; J M Papadimitriou; D Causer
Journal:  Genetica       Date:  1995       Impact factor: 1.082

9.  Human immunodeficiency virus contains an epitope immunoreactive with thymosin alpha 1 and the 30-amino acid synthetic p17 group-specific antigen peptide HGP-30.

Authors:  P H Naylor; C W Naylor; M Badamchian; S Wada; A L Goldstein; S S Wang; D K Sun; A H Thornton; P S Sarin
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

10.  Immunogenicity of human immunodeficiency virus (HIV) reverse transcriptase: detection of high levels of antibodies to HIV reverse transcriptase in sera of homosexual men.

Authors:  R Chatterjee; C R Rinaldo; P Gupta
Journal:  J Clin Immunol       Date:  1987-05       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.